Post Market Clinical Follow-Up Under EU MDR

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...

EUDAMED Timeline Update

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...

MDR NB Common Submission Issues and How to Prevent Them

Fang’s internal processes and checklists have evolved over the last 3 years since we started working...

Class I Devices Under MDR: To NB, Or Not To NB?

Note: The following discussion applies to non-custom, non-investigational medical devices. If you...

Stay Calm and Carry On: What Brexit Means for Your Medical Device

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...

Tracy Eberly and Fang Consulting Discuss Choosing the Best Firm for Your Needs

In a field as innovative and diverse as the medical device industry, finding the right consulting fi...

Notified Bodies

With the EU MDR (2017/745) replacing the current MDD (93/42/EEC) in the EU, many changes are on ...